Log in to your Inderes Free account to see all free content on this page.
SpectraCure
0.08 SEK
-1.40 %
Less than 1K followers
SPEC
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.40 %
+23.03 %
-17.09 %
-45.83 %
-46.65 %
-73.36 %
-96.08 %
-97.69 %
-86.48 %
SpectraCure operates in the medical technology sector. The company specializes in research and development of medical technology systems used for the treatment of prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internal solid tumors of various types. The largest operations are found in the Nordic market. The company has its headquarters in Lund.
Read moreMarket cap
48.16M SEK
Turnover
71.64K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.5.
2026
Interim report Q1'26
27.5.
2026
General meeting '26
14.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
A well-accomplished annual audit in accordance with ISO 13485:2016
Expert group comments on results of ongoing study
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio